(Q35987052)

English

BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases (English)

1 reference

Europe PubMed Central

11 August 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

Gregg C. Fonarow

9

object named as

Gregg Fonarow

1 reference

Europe PubMed Central

11 August 2017

3

object named as

Clyde W Yancy

1 reference

Europe PubMed Central

11 August 2017

Mandeep R. Mehra

7

object named as

Mandeep R Mehra

1 reference

Europe PubMed Central

11 August 2017

author name string

Marc A Silver

1

1 reference

Europe PubMed Central

11 August 2017

Alan Maisel

2

1 reference

Europe PubMed Central

11 August 2017

Peter A McCullough

4

1 reference

Europe PubMed Central

11 August 2017

John C Burnett

5

1 reference

Europe PubMed Central

11 August 2017

Gary S Francis

6

1 reference

Europe PubMed Central

11 August 2017

William Franklin Peacock

8

1 reference

Europe PubMed Central

11 August 2017

W Brian Gibler

10

1 reference

Europe PubMed Central

11 August 2017

David A Morrow

11

1 reference

Europe PubMed Central

11 August 2017

Judd Hollander

12

1 reference

Europe PubMed Central

11 August 2017

BNP Consensus Panel

13

1 reference

Europe PubMed Central

11 August 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

11 August 2017

Congestive Heart Failure

1 reference

Europe PubMed Central

11 August 2017

10

1 reference

Europe PubMed Central

11 August 2017

5 Suppl 3

1 reference

Europe PubMed Central

11 August 2017

1-30

1 reference

Europe PubMed Central

11 August 2017

Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Quality of care for elderly patients hospitalized with heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma brain natriuretic peptide concentration: impact of age and gender

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Promises and perils of managed care for older patients with cardiac disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Measurement and importance of plasma brain natriuretic peptide and related peptides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Effects of prehospital medications on mortality and length of stay in congestive heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma brain natriuretic peptide in assessment of acute dyspnoea.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B-type Natriuretic Peptide in the Emergency Department

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Obesity and the risk of heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Expression of natriuretic peptide receptors in human adipose and other tissues.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Obesity and suppressed B-type natriuretic peptide levels in heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Impact of obesity on plasma natriuretic peptide levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Ventak CHF Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Readmission after hospitalization for congestive heart failure among Medicare beneficiaries.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Clinical cardiovascular databases: ready for prime time?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Tailored therapy to hemodynamic goals for advanced heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Transient reduction without normalization of brain natriuretic peptide early after heart transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Intravenous nesiritide (human B-type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Molecular biology of the natriuretic peptides and their receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Inotropic infusions for chronic congestive heart failure: medical miracles or misguided medicinals?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Cardiac fibrosis in mice lacking brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Subcutaneous administration of brain natriuretic peptide in experimental heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Significance of Raised Natriuretic Peptides After Bicaval and Standard Cardiac Transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Identifiers

10.1111/J.1527-5299.2004.03271.X

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35987052&oldid=1703963444"